Glaxo 2Q Core EPS Beats Estimates, Improves Core EPS Outlook
Source: BFW (Bloomberg First Word)
Tickers
GSK LN (GlaxoSmithKline PLC)
To de-activate this alert, click here
UUID: 7947283
(Bloomberg) -- Co. now expects core EPS percentage growth to be 11%-12% at constant FX.
Alert: HALISTER- 2Q turnover/revenue: GBP6.53b vs est. GBP6.34b
- 2Q core EPS GBP24.5p vs est. 21p
- 2Q core operating profit: GBP1.83b vs est. GBP1.63b
- Statement
- Conf. call at 2pm; dial-in: +44 1296 480 100; PIN: 52354507
- NOTE: Yday, PREVIEW GLAXO 2Q: Weak British Pound May Boost Reported Earnings
- Earlier, Glaxo to Invest $360 Million in Three U.K. Manufacturing Sites
Source: BFW (Bloomberg First Word)
Tickers
GSK LN (GlaxoSmithKline PLC)
To de-activate this alert, click here
UUID: 7947283